Abstract - Imperial College London
A fundamental property of many cancers is the ability to avoid the host immune response and allow cell proliferation and metastasis. Harnessing the immune system to target cancer has been a strategy employed in oncology for many decades.1 A major advance in the last 10 years is the use of immune checkpoint inhibitors (ICIs) to block the inhibitory receptors such at cytotoxic lymphocyte ... ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.